The first congratulatory report from a listed insurance company: Xinhua's net profit growth rate may exceed 175%, setting a record in sight.
As listed companies have been frequently announcing "good news," the first report card of A-share insurance companies has finally been released. On January 20, New China Life Insurance disclosed the company's results for 2024...
Huadong Medicine has obtained approvals for three new products at the start of the year, which is nearly half of last year's total.|Quick read announcement.
① Huadong Medicine announced today that three products have received approval for market release, while a total of seven products were approved for market release last year; ② Among them, a hyaluronic acid product in the medical aesthetics category and a Chemical Drug for treating ovarian cancer received domestic approval, while a medical instrument for evaluating kidney function received approval in the USA; ③ Huadong Medicine believes that the approvals will not have a significant impact on the current financial condition and Operating results of the company.
The hydropower giant with a market cap of 700 billion achieved record high performance last year, and the power generation of six ladder power stations increased year-on-year | Interpretations
1. In 2024, China Yangtze Power's net profit exceeded 30 billion yuan, earning approximately 89 million yuan daily; 2. This is the best performance achieved by China Yangtze Power since its listing in 2003, although the net profit for Q4 showed a year-on-year decline.
Under the new accounting standards, performance fluctuations have increased! New China Life Insurance turned a loss into profit year-on-year in the fourth quarter of last year, but performance dropped sharply compared to the previous quarter.
①The net income for 2024 is expected to increase from 23.958 billion yuan to 25.7 billion yuan, a year-on-year growth of 175% to 195%; ②In the first three quarters of 2024, New China Life Insurance's investment income and fair value change income totaled 47.119 billion yuan; ③With the recovery of the capital markets and the increase in the proportion of equity asset allocation, New China Life Insurance's investment returns have surged.
Is the industry leader also under pressure? Poly Developments and Holdings Group's performance declines in 2024, initiating structural adjustments.
Poly Developments and Holdings Group recently announced adjustments to its organizational structure, mainly involving the merger of regional companies and personnel changes; before and after this restructuring by Poly Developments and Holdings Group, it coincides with the announcement of a decline in revenue and net profit for 2024.
Breaking! The leading company of phased array TR chips announces a possible (Delisted) risk warning | After-hours announcement highlights.
Baolingbao: The company's products involved in the case have been subjected to a 34.4% anti-dumping duty by the EU, while other related companies in China have been subjected to anti-dumping duties ranging from 78.4% to 233.3%.